PACB

NASDAQ 已收盘

Pacific Biosciences of California, Inc.

1.44 USD
+0.02+1.41%
盘后 1.43 +0.58%
2026-08-03
市值
$447.27M
市盈率
EPS
-0.42
股息率
52 周区间
1.09 – 2.73
成交量
6.40M
Beta
2.29
目标价
2.46
52W 低 1.0952W 高 2.73
价格走势

公司简介

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified...